EntryPoint Capital LLC Sells 35,371 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

EntryPoint Capital LLC reduced its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 81.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,109 shares of the company’s stock after selling 35,371 shares during the period. EntryPoint Capital LLC’s holdings in AdaptHealth were worth $93,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Wakefield Asset Management LLLP bought a new position in shares of AdaptHealth during the first quarter valued at about $1,007,000. Federated Hermes Inc. raised its position in AdaptHealth by 672.8% in the fourth quarter. Federated Hermes Inc. now owns 705,125 shares of the company’s stock worth $5,140,000 after acquiring an additional 613,882 shares during the period. Reinhart Partners LLC. raised its position in AdaptHealth by 3.6% in the first quarter. Reinhart Partners LLC. now owns 4,210,211 shares of the company’s stock worth $48,460,000 after acquiring an additional 144,516 shares during the period. Hillsdale Investment Management Inc. bought a new stake in AdaptHealth in the first quarter worth about $4,240,000. Finally, First Eagle Investment Management LLC raised its position in AdaptHealth by 18.2% in the first quarter. First Eagle Investment Management LLC now owns 594,951 shares of the company’s stock worth $6,848,000 after acquiring an additional 91,772 shares during the period. 82.67% of the stock is owned by institutional investors.

AdaptHealth Price Performance

Shares of AHCO stock traded down $0.23 during trading hours on Friday, reaching $11.30. The stock had a trading volume of 423,047 shares, compared to its average volume of 1,047,609. The stock’s fifty day simple moving average is $10.41 and its 200 day simple moving average is $9.55. The company has a current ratio of 1.33, a quick ratio of 1.11 and a debt-to-equity ratio of 1.48. AdaptHealth Corp. has a 12 month low of $6.37 and a 12 month high of $15.37. The firm has a market capitalization of $1.51 billion, a PE ratio of -2.19, a PEG ratio of 0.78 and a beta of 1.10.

AdaptHealth (NASDAQ:AHCO) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.04). AdaptHealth had a negative net margin of 21.45% and a positive return on equity of 8.47%. The firm had revenue of $792.50 million during the quarter, compared to the consensus estimate of $771.08 million. On average, equities research analysts predict that AdaptHealth Corp. will post 0.82 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Truist Financial reaffirmed a “buy” rating and issued a $13.00 price objective on shares of AdaptHealth in a research report on Wednesday, May 15th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $10.70.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.